K

Ketryx

SaaS platform for regulated medical software

Growth Account Executive

Full-Time
$160k - $180k+ Equity options
Mid, Senior
Boston, MA, USA
Hybrid
Sales & Account ManagementAccount Executive

About the job

Requirements
  • Have 3–5 years of business-to-business software-as-a-service sales experience.
  • Have proven success negotiating and closing deals in complex sales cycles.
  • Be able to quickly grasp highly complex technical concepts.
  • Have strong written and verbal communication, presentation, and interpersonal skills, including the ability to engage decision-makers.
  • Be able to convey complex solutions clearly and compellingly.
  • Have a track record of meeting or exceeding sales targets.
  • Have strong organizational skills and habits.
  • Be proactive and open to learning and growing in a fast-paced startup environment.
  • Have a passion for healthcare technology and the ability to connect with leaders in the medical device industry.
  • Currently be in the Greater Boston area and willing to work in the office, or be able to relocate immediately.
Responsibilities
  • Prospect, qualify, and close deals with small and medium-sized business and mid-market customers in regulated industries.
  • Educate prospects on how Ketryx transforms compliance and development workflows.
  • Run organized, well-orchestrated sales cycles with cross-functional internal support.
  • Own and exceed the sales quota through rigor, urgency, and a deep understanding of customer pain.
  • Ramp quickly, learn quickly, and adapt to the pace and ambiguity of a high-growth startup.
  • Help shape the sales playbook and raise the bar across the sales team by sharing effective practices.
  • Guide the customer experience from first contact through renewal, with support from sales engineers, marketing, and client operations.
Desired Qualifications
  • Previous experience in a startup environment is strongly preferred.
  • A background in Engineering, Life Sciences, or another regulated industry is preferred.

About the company

Ketryx offers a SaaS Connected Lifecycle Management platform for regulated medical software. It guides the full lifecycle from planning through verification and maintenance, ensuring compliance with FDA, IEC 62304, GMP, ISO 13485, and CFR 21 Part 11. The platform integrates traceability, documentation, Jira, and SBOM management to streamline development, quality, and compliance. It targets MedTech teams from startups to large enterprises, aiming to reduce compliance risk and development costs while speeding time to market.

Company Size

51-200

Company Stage

Series B

Total Funding

$57.1M

Headquarters

Cambridge, Massachusetts

Founded

2021

Get referred to Ketryx

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Ketryx raised $39 million on September 4, 2025, led by Transformation Capital.
  • Ketryx announced MCP beta on March 31, 2026, embedding compliance into AI workflows.
  • Four of five top Fortune 500 MedTech companies now run on Ketryx.

What critics are saying

  • FDA warning letters on AI usage in 2026 punish weak human oversight and validation.
  • Siemens Healthineers, Veeva, and Jama can bundle compliance into existing enterprise contracts.
  • If Ketryx loses trust in auditability, regulated buyers stop deployments immediately.

What makes Ketryx unique

  • Ketryx launched validated AI agents on May 1, 2025, for regulated medical workflows.
  • Ketryx holds ISO 13485, IEC 62304, ISO 27001, and SOC 2 Type II.
  • Ketryx serves Meta Reality Labs, Flo Health, DeepHealth, HeartFlow, and Fortune 500 MedTech.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Hybrid Work Options
  • Unlimited Paid Time Off
  • Stock Options

Growth & Insights and Company News

Headcount

6 month growth

2%

1 year growth

9%

2 year growth

7%
VentureFizz
Sep 30th, 2025
Hiring Unlocked: Ketryx Event Video - Company Details, Jobs, Culture, and More

Recently, Ketryx announced a $39M Series B round of funding led by Transformation Capital, with participation from existing investors including Lightspeed Venture Partners, MIT's E14 Fund, Ubiquity Ventures, and 53 Stations.

FinSMEs
Sep 4th, 2025
Ketryx Raises $39M in Series B Funding

Ketryx, a Cambridge, MA-based AI-powered compliance platform helping life sciences companies ship safer products faster, raised $39M in Series B funding

PR Newswire
Sep 4th, 2025
Ketryx Raises $39M Series B Round to Power the Future of Regulated Artificial Intelligence for Life Sciences

Ketryx raises $39M Series B round to power the future of regulated artificial intelligence for life sciences.

SiliconANGLE Media
Sep 4th, 2025
Ketryx raises $39M to help medical device makers ship safer products faster

Ketryx Corp., a company transforming product lifecycle development and compliance for medical device makers with artificial intelligence, today announced it has raised $39 million in a Series B funding round led by Transformation Capital.

TechIntelPro
May 2nd, 2025
Ketryx Launches First Validated AI Agents to Accelerate Safety-Critical Product Development

Ketryx launches first validated AI Agents to accelerate safety-critical product development.